IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · IEX Real-Time Price · USD
1.190
-0.030 (-2.46%)
At close: Apr 25, 2024, 4:00 PM
1.180
-0.010 (-0.84%)
After-hours: Apr 25, 2024, 6:53 PM EDT
IceCure Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IceCure Medical stock have an average target of 2.95, with a low estimate of 2.90 and a high estimate of 3.00. The average target predicts an increase of 147.90% from the current stock price of 1.19.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ICCM stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +152.10% | Apr 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +152.10% | Apr 4, 2024 |
Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $1.9 → $2.9 | Strong Buy | Maintains | $1.9 → $2.9 | +143.70% | Mar 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +152.10% | Mar 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +152.10% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
4.87M
from 3.23M
Increased by 50.70%
Revenue Next Year
15.56M
from 4.87M
Increased by 219.79%
EPS This Year
-0.29
from -0.32
EPS Next Year
-0.25
from -0.29
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 6.6M | 28.0M | 35.6M |
Avg | 4.9M | 15.6M | 34.5M |
Low | 3.7M | 6.7M | 33.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 104.9% | 476.1% | 128.5% |
Avg | 50.7% | 219.8% | 122.0% |
Low | 13.8% | 37.0% | 113.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.25 | -0.24 | - |
Avg | -0.29 | -0.25 | - |
Low | -0.30 | -0.26 | - |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.